VirusExpress® Platform For Lentivirus
Source: MilliporeSigma

Discover an experienced partner with an unparalleled track record and solutions to de-risk the production of your cell or gene therapy. Trusted to advance lentiviral cell and gene therapies for three decades, MilliporeSigma has the expertise to support your therapeutic from preclinical development through commercialization. Continue reading to learn about the ultimate solution to bring your lentivirus-based cell or gene therapy to GMP in less than 12 months.
access the Brochure!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
MilliporeSigma
This website uses cookies to ensure you get the best experience on our website. Learn more